Uncommon EGFR mutations associate with lower incidence of T790M mutation after EGFR-TKI treatment in patients with advanced NSCLC.
Yang S, Mao S, Li X, Zhao C, Liu Q, Yu X, Wang Y, Liu Y, Pan Y, Wang C, Gao G, Li W, Xiong A, Chen B, Sun H, He Y, Wu F, Chen X, Su C, Ren S, Zhou C.
Yang S, et al. Among authors: mao s.
Lung Cancer. 2020 Jan;139:133-139. doi: 10.1016/j.lungcan.2019.11.018. Epub 2019 Nov 24.
Lung Cancer. 2020.
PMID: 31786475
Clinical Trial.